Loading organizations...
Loading organizations...
Biotechnology company developing genetic medicines with nanoparticle platfo
BreezeBio has raised $60.0M across 1 funding round.
BreezeBio has raised $60.0M in total across 1 funding round.
BreezeBio has raised $60.0M in total across 1 funding round.
BreezeBio's investors include DSC Investment, ACVC Partners, Daily Partners, Kiwoom Investment, Korea Development Bank, Korea Investment Partners, LoftyRock Investment, Pathway Capital Management, STIC Ventures, SV Investment, Top Harvest Capital, Woori Venture Partners.
BreezeBio has raised $60.0M across 1 funding round. Most recently, it raised $60.0M Series B in February 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 25, 2026 | $60.0M Series B | DSC Investment | ACVC Partners, Daily Partners, Kiwoom Investment, Korea Development Bank, Korea Investment Partners, LoftyRock Investment, Pathway Capital Management, STIC Ventures, SV Investment, Top Harvest Capital, Woori Venture Partners |